Royal Bank of Canada
ARRY

Royal Bank of Canada’s Array Biopharma Inc ARRY Stock Holding History

Royal Bank of Canada’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-221,330
Closed -$10.3M – 7461
2019
Q2 		$10.3M Buy
221,330
+159,173
+256% +$4.47M ﹤0.01% 1548
2019
Q1 		$1.51M Buy
62,157
+29,453
+90% +$613K ﹤0.01% 2888
2018
Q4 		$466K Buy
32,704
+21,174
+184% +$321K ﹤0.01% 3756
2018
Q3 		$175K Buy
11,530
+1,392
+14% +$21.3K ﹤0.01% 4547
2018
Q2 		$171K Sell
10,138
-2,736
-21% -$43.5K ﹤0.01% 4501
2018
Q1 		$211K Buy
12,874
+9,363
+267% +$150K ﹤0.01% 4293
2017
Q4 		$44K Sell
3,511
-15,109
-81% -$172K ﹤0.01% 5232
2017
Q3 		$229K Buy
18,620
+17,684
+1,889% +$164K ﹤0.01% 4418
2017
Q2 		$8K Sell
936
-6,328
-87% -$51.7K ﹤0.01% 5905
2017
Q1 		$65K Sell
7,264
-37,315
-84% -$397K ﹤0.01% 5014
2016
Q4 		$392K Buy
44,579
+40,769
+1,070% +$300K ﹤0.01% 3962
2016
Q3 		$26K Sell
3,810
-7,500
-66% -$29K ﹤0.01% 5450
2016
Q2 		$40K Sell
11,310
-4,280
-27% -$13.9K ﹤0.01% 5213
2016
Q1 		$45K Sell
15,590
-19,945
-56% -$59.8K ﹤0.01% 5175
2015
Q4 		$151K Sell
35,535
-12,340
-26% -$56.3K ﹤0.01% 4712
2015
Q3 		$218K Buy
47,875
+37,554
+364% +$223K ﹤0.01% 4248
2015
Q2 		$74K Buy
+10,321
New +$76.2K ﹤0.01% 5005
2014
Q3 		– Sell
-16,225
Closed -$74K – 6227
2014
Q2 		$74K Buy
16,225
+12,825
+377% +$53K ﹤0.01% 4679
2014
Q1 		$16K Sell
3,400
-21,936
-87% -$110K ﹤0.01% 5284
2013
Q4 		$127K Sell
25,336
-624
-2% -$3.4K ﹤0.01% 4450
2013
Q3 		$161K Buy
25,960
+4,706
+22% +$28K ﹤0.01% 4213
2013
Q2 		$97K Buy
+21,254
New +$114K ﹤0.01% 4327

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Royal Bank of Canada's ARRY Position: Q3 2019 in Review

Royal Bank of Canada sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 221,330 shares — an estimated $10.3M sold.

Royal Bank of Canada first reported a position in ARRY in Q2 2013 and held it in 22 quarters. The position peaked at $10.3M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Royal Bank of Canada reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Royal Bank of Canada sold 221,330 Array Biopharma Inc shares in Q3 2019, an estimated $10.3M.
  • Royal Bank of Canada first reported a position in Array Biopharma Inc in Q2 2013 and held it in 22 quarters.
  • Royal Bank of Canada's Array Biopharma Inc position peaked at $10.3M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Royal Bank of Canada's 13F filing for Q3 2019, filed 14 Nov 2019.